Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
- 4 April 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (15) , 2328-2333
- https://doi.org/10.1038/sj.onc.1205402
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 16 references indexed in Scilit:
- Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype SuppressionJNCI Journal of the National Cancer Institute, 2001
- Somatic mutation of thehBUB1 mitotic checkpoint gene in primary lung cancerGenes, Chromosomes and Cancer, 2000
- Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 2000
- High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancerProceedings of the National Academy of Sciences, 2000
- DNA hypermethylation in tumorigenesis: epigenetics joins geneticsTrends in Genetics, 2000
- Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancersOncogene, 1999
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Cell Cycle Checkpoints: Preventing an Identity CrisisScience, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLCScience, 1988